An FDA panel backed Grail’s Galleri test. But the Medicare money the business depends on is far from guaranteed.

Or had her cancer returned? “Because I have the BRCA2 gene, I have a higher chance of the cancer coming back,” she says. “The ...

Michelle York got tested for Lynch syndrome, an under-diagnosed and symptomless genetic condition that raises cancer risk.

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, today announced the launch of the Riskguard™ hereditary cancer test in the United ...

Researchers developed a urine test that detects bladder cancer, predicts which patients will benefit from immunotherapy ...

The panelists expressed reservations about the evidence supporting Grail’s Galleri test, which is designed to detect cancers ...

Given what some experts and clinicians cite as a lack of clear evidentiary benefit, FDA approval doesn’t guarantee reimbursement of multi-cancer early detection tests.

A new urine test could identify people with bladder cancer more accurately than current diagnostic methods, researchers found ...

Age, female sex, genetics and family history are important risk factors. Having a mother, sister or daughter with breast ...

October is Breast Cancer Awareness Month and a TTUHSC doctor is offering advice on when to screen, what to watch for and how ...

An advisory panel to the US Food and Drug Administration handed Grail's Galleri blood test a milestone win last week, saying the early cancer detection test's potential benefits outweigh its risks and ...